ReviewCureus2025
Radiological Differentiation of Pituitary Adenomas From Other Sellar Masses: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sellar masses frequently share overlapping magnetic resonance imaging (MRI) appearances, yet management and prognosis vary across entities such as pituitary adenoma, Rathke cleft cyst (RCC), and craniopharyngioma. Improving preoperative discrimination would support surgical planning and endocrine outcomes. This review synthesizes comparative radiologic features and adjunct sequences that differentiate sellar masses and appraises the methodological quality of recent studies. We conducted a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. We collected data from these databases: PubMed, Cochrane Library, ScienceDirect, Oxford Academic, American Journal of Neuroradiology (AJNR), and MDPI. We extracted relevant data from screening and quality appraisal with quality appraisal tools according to the respective study. Fifteen studies met criteria after full-text assessment. Two higher-quality diagnostic studies showed that combining structured semantic MRI features with radiomics or simple clinical indices improved discrimination in common differentials (cystic pituitary adenoma vs. RCC; cystic-solid adenoma vs. craniopharyngioma). Diffusion-weighted imaging and high-resolution 3D T2 sequences provided supportive gains in confidence and detection, although thresholds and verification strategies varied. Across JBI and QUADAS-2, the most frequent limitations were retrospective design, unclear index-test blinding/pre-specification, and partial verification in sequence-evaluation cohorts. Structured semantic MRI remains foundational for sellar mass work-up; thoughtfully integrated radiomics and selective adjunct sequences can increase diagnostic confidence. Standardized acquisition, prespecified thresholds, and external validation are needed before universal protocol adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.